International Registry of Coronavirus (COVID-19) Exposure in Pregnancy
NCT ID: NCT04366986
Last Updated: 2021-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
17318 participants
OBSERVATIONAL
2020-06-23
2021-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID-19 International Drug Pregnancy Registry
NCT05013632
COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY)
NCT04323839
Obstetric and Perinatal Outcomes of Women With COVID-19
NCT04369859
Covid-19 Infection in Pregnancy
NCT04869202
Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19
NCT04718220
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Women will enroll and provide information to the IRCEP via website and mobile app. After signing the electronic informed consent document, registrants will answer questions on the following modules: Demographics, Reproductive History, Height and Weight, Habits, Health Conditions, Medications, Current Pregnancy, COVID-19 Infection Test, and COVID-19 Infection Symptoms. Monthly follow-up modules will continue until the pregnancy outcome. In case of a live birth, the Registry participant will continue with the Post-Partum Outcomes module until the newborn is 90 days of age. Medical records from the mother and neonate will also be requested.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregnant Women
Women who are currently pregnant
Tested for SARS-CoV-2 (regardless of the result)
This is an observational study with no intervention
Clinical diagnosis of COVID-19 by a health care professional
This is an observational study with no intervention
Post-partum women
Women who have been pregnant in the past 6 months
Tested for SARS-CoV-2 (regardless of the result)
This is an observational study with no intervention
Clinical diagnosis of COVID-19 by a health care professional
This is an observational study with no intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tested for SARS-CoV-2 (regardless of the result)
This is an observational study with no intervention
Clinical diagnosis of COVID-19 by a health care professional
This is an observational study with no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to give electronic informed consent
* Tested for SARS-CoV-2 (regardless of the result) or clinically diagnosed with COVID-19 by a health care professional
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Harvard School of Public Health (HSPH)
OTHER
Pregistry
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Diego Wyszynski, MD, MHS, PhD
Role: PRINCIPAL_INVESTIGATOR
CEO Pregistry
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pregistry
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
International Registry of Coronavirus (COVID-19) Exposure in Pregnancy
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.